Introduction {#sec1-1}
============

Rotavirus and norovirus are common pathogens associated with gastroenteritis in children.^[@ref1]^ Although they could induce central nervous system disease, only 3 cases with rotavirus-induced acute myositis have been reported in the English literature.^[@ref2]^ Acute myositis is often caused by various infectious pathogens, such as mycoplasma pneumonia, influenza virus and adenovirus.^[@ref5]^ In contrast, acute myositis associated with rotavirus or norovirus is seldom reported. Rotavirus-associated muscle damage can be life threatening as a result from rhabdomyolysis or cardiac muscle impairment,^[@ref4],[@ref6]^ but the mechanism responsible for the development of muscle damage remains unknown. Therefore, additional case reports are warranted to determine the epidemiology and pathogenesis underlying rotavirus-associated muscle damage.

Case Report {#sec1-2}
===========

A 2.5-year-old female patient was referred to our department complaining that she was not able to move her lower extremities coincidence with elevated serum creatine phosphokinase (CK) and CK-MB levels. She had been receiving infusion for fever, vomiting and diarrhea resulting from rotavirus-associated gastroenteritis for 3 days before being referred to our hospital. Diagnosis of rotavirus-induced gastroenteritis was made based on frequent diarrhea and the presence of rotavirus antigen in her stool. In addition to Group A rotavirus, norovirus (G2) was also isolated from her stool in the subsequent analysis. Her fever and diarrhea resolved in the first 3 days. However, on day 4, she was reluctant to move her lower extremities and was unable to stand or walk ([Figure 1](#fig001){ref-type="fig"}), whereas she was able to move her upper extremities normally. While her serum CK level was 133 IU/L (reference: 36-216 IU/L) the day before infusion (day 1), it was elevated to 5547 IU/L on day 4 when she was not able to move her legs. CK-MB was 122 IU/L, which was over the normal limit (reference value \<25 IU/L). Hence, she was suspected to be suffering from acute myocarditis, one of several rare complications associated with rotavirus infection.^[@ref5]^ Her past history was unremarkable with no evidence of any developmental delays, although she did have a respiratory tract infection approximately 13 days before hospitalization. She had not received a vaccination against rotavirus. There was no tenderness on her leg muscle. Her patellar tendon reflex and Achilles tendon reflex were normal on both sides. She showed no signs of consciousness disturbance or cerebellar ataxia. Neither abdominal masses nor breathing difficulties were identified. Her cardiac sound and echocardiography (ECG) were normal. Echocardiography indicated her ejection fraction index was 79% without any signs of cardiac effusion. Chest X-ray revealed that her cardio thoracic ratio was 55% and pulmonary effusion was not detected. Troponin T was negative, and BNP was 11.2 pg/mL (reference value \<20 pg/mL). The titer of serum CK was 4,930 IU/L, but 99.1% of CK was MM type and only 0.7% was CK-MB, as determined by electrophoresis of CK fraction. These findings suggested that cardiac muscle damage was highly unlikely, which was opposed to what was initially suspected. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) were 240 IU/L, 66 IU/L and 352 IU/L, respectively. Aldolase was 55.5 IU/L (reference value \<7.5 IU/L). Serum Na, K, Cl, Mg and Ca were all in a normal range. Soluble IL-2 receptor was elevated to 2,509 U/ml. Blood TSH, free T3 and free T4 were normal. Mycoplasma antibody was negative. Influenza virus, adenovirus, RS virus and Streptococcus pyogenes were not detected by throat swab. EBV-associated antibodies were not elevated. Anti JO-1 antibody and anti-nucleus antibody were negative. Fatty acid analysis using tandem mass spectrometry did not show any abnormal findings. Within 4 days, muscle weakness disappeared and her leg movement normalized ([Figure 1](#fig001){ref-type="fig"}). Resolution of her symptoms was accompanied by a CK reduction to 294 IU/L. These findings demonstrate that the patient was affected with acute myositis following simultaneous infection with rotavirus and norovirus. On day 8, she was able to walk home.

Discussion {#sec1-3}
==========

The diagnosis of benign acute myositis in children is usually made based on the typical clinical symptoms, such as symmetrical calf muscle pain, tenderness, inability or refusal to walk a few days after infectious illness, CK elevation that normalizes within 1 week.^[@ref7]^ Although most reported cases with virus associated benign myositis were diagnosed without electrophysiological or cerebrospinal fluid examination,^[@ref2],[@ref3],[@ref7]^ these studies would help to exclude other diseases such as Guillain-Barré syndrome. However, our patient demonstrated elevation of CK up to 5547 U/L, which is not usually observed in Guillain-Barré syndrome. Moreover, rapid resolution of the clinical symptom associated with concomitant decline in CK level indicates that the damaged tissue was muscle, making it highly unlikely that the girl was affected with Guillain-Barré syndrome. These clinical and laboratory findings were entirely consistent with benign acute myositis as reported in the previous literature,^[@ref2],[@ref3]^ which led to the diagnosis of our patient as acute myositis.

Acute myositis is often caused by infectious pathogens such as mycoplasma pneumonia, influenza virus and adenovirus.^[@ref5]^ Although concurrent infection of norovirus and rotavirus in acute myositis has never been described, our patient developed myositis following infection with the combination of these viruses. Previous reports demonstrating an association between rotavirus infection and myositis on rare occasions suggest that myositis was more likely attributed to rotavirus rather than norovirus in our case.^[@ref2]^ However, the involvement of norovirus could not be excluded (see below). The mechanism responsible for rotavirus associated myositis is yet to be determined, but it is considered a consequence of direct virus invasion into muscle or an immunological reaction.^[@ref5],[@ref8]^ A particular subtype of rotavirus may be associated with muscle tropism, although virus subtypes were not determined in our case or in other reports. Our patient developed myositis following cessation of gastroenteritis symptoms, which is similar to other reported cases ([Table 1](#table001){ref-type="table"}),^[@ref2],[@ref9]^ suggesting that an indirect mechanism is likely responsible, rather than direct invasion of the virus into skeletal muscle. The pathogenesis of acute myositis remains unknown, although the immune mediated mechanisms initiated by the hosts are suspected.^[@ref2],[@ref7]^ Elevation of soluble IL-2R in our case suggests activation of T-cells and immune dysregulation, which might have contributed to the development of myositis. With respect to the acute myositis and the immune dysregulation, infection with parvovirus B19 is associated with autoimmune acute dermatomyositis.^[@ref13]^ However, our patient did not demonstrate elevation auto-antibodies that are known to be involved in immune myositis. Although an association between norovirus and acute myositis has never been reported, norovirus could have been the causative pathogen for the muscle damage in our case. While the cellular tropism of noroviruses has not been defined, it has been reported that norovirus RNA was detected in the serum of infected children and in the cerebrospinal fluid in cases presenting with encephalopathy, indicating extraintestinal spread in the infected individuals.^[@ref8]^ However, it remains to be determined whether norovirus can directly invade muscle or indirectly cause myositis. Alternatively, norovirus may have modulated the immunological reaction of the patient in response to rotavirus, which subsequently resulted in myositis. Indeed, norovirus infection regulates the interferon response in mice, suggesting that noroviruses can modulate host immunological responses.^[@ref14],[@ref15]^

The majority of patients with rotavirus-associated myositis, as well as our patient, are over 2 years old ([Table 1](#table001){ref-type="table"}). In contrast, most children with rotavirus gastroenteritis are generally younger than 2 years of age, suggesting that rotavirus-induced myositis could be age dependent. However, the number of patients may be underestimated because the majority of subjects affected with rotavirus are generally infants who have yet to walk, making any gait disturbance difficult to notice. In contrast, influenza virus or mycoplasma pneumonia normally affects older children; therefore, their gait disturbance is more likely to be recognized. Blood CK activity in our case was normal before the manifestation of muscle weakness, which quickly returned to normal, thus excluding congenital muscular dystrophy or myopathy. Most cases reported so far, including ours, recovered in a short time. Yet, in rare situations, cardiac muscle damage or rhabdomyolysis is a serious complication.^[@ref5],[@ref16]^ Although CK-MB activity was over the normal range in our case, her cardiac function was normal, suggesting that the elevation of CK-MB activity in our case was most likely derived from skeletal muscle.

Conclusions {#sec1-4}
===========

We documented a female patient with acute myositis associated with gastroenteritis induced by concomitant infection with rotavirus and norovirus. Development of myositis following cessation of gastroenteritis symptoms suggested an indirect mechanism was responsible rather than direct virus invasion. The causative pathogen was likely rotavirus in our case. However, it is possible that norovirus was also involved. In this regard, additional case accumulation is warranted to determine if norovirus can indeed result in acute myositis or if a combination of rotavirus and norovirus increases the risk of developing muscle inflammation. Because virus induced acute myositis can result in rhabdomyolysis or cardiac muscle damage, physicians should be aware of acute myositis as a potential complication of gastroenteritis induced by rotavirus or possibly norovirus.
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![Clinical course and serum creatine phosphokinase activity of the patient. The patient was referred to our department on day 4 following 3 days of infusion for gastroenteritis. While she did not have fever, vomiting and/or diarrhea on the day of referral, she was not able to stand or walk. However, she recovered within 4 days without any medication.](pr-2015-3-5873-g001){#fig001}

###### 

Cases manifesting creatine phosphokinase (CK) elevation during the course of rotavirus infection.

  Age     Gender   CK max (IU/L)   Symptoms                                                              Onset day   Days to recovery   Reference
  ------- -------- --------------- --------------------------------------------------------------------- ----------- ------------------ -----------------------------
  2.7 y   F        3675            Unable to walk                                                        5           4                  Hattori *et al.*^[@ref3]^
  1.2 y   F        5398            Unable to walk                                                        5           7                  Nakazawa *et al*.^[@ref9]^
  2 y     M        7381            Unable to walk                                                        6           13                 Bonno *et al.*^[@ref2]^
  1 y     M        7952            Cerebral palsy, macro CK, hyper CK was associated with hyper tonus.   5           30                 Hasui *et al.*^[@ref10]^
  8 y     F        9861            Inability to hold the body, encephalopathy                            3           5                  Fukumura *et al.*^[@ref11]^
  7 y     F        5118            Muscle weakness                                                       2           9                  Fukumura *et al.*^[@ref11]^
  6 m     M        105,959         Encephalopathy, rhabdomyolysis                                        3           44                 Minami *et al.*^[@ref4]^
  1 y     M        2022            Cardiac effusion, macro CK                                            3           15                 Oda *et al.*^[@ref12]^
  2.5 y   F        5547            Unable to walk                                                        4           4                  Present case
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